IOL Chemicals and Pharmaceuticals Limited (BOM:524164)
128.69
-2.65 (-2.02%)
At close: May 29, 2026
BOM:524164 Revenue
In the fiscal year ending March 31, 2026, IOL Chemicals and Pharmaceuticals had annual revenue of 23.19B INR with 11.54% growth. IOL Chemicals and Pharmaceuticals had revenue of 6.19B in the quarter ending March 31, 2026, with 17.37% growth.
Revenue
23.19B
Revenue Growth
+11.54%
P/S Ratio
1.63
Revenue / Employee
8.02M
Employees
2,891
Market Cap
37.77B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 23.19B | 2.40B | 11.54% |
| Mar 31, 2025 | 20.79B | -535.80M | -2.51% |
| Mar 31, 2024 | 21.33B | -843.20M | -3.80% |
| Mar 31, 2023 | 22.17B | 330.90M | 1.52% |
| Mar 31, 2022 | 21.84B | 2.17B | 11.03% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Neuland Laboratories | 20.23B |
| Shilpa Medicare | 15.49B |
| Bajaj HealthCare | 6.11B |
| NGL Fine-Chem | 5.01B |
| Aarey Drugs & Pharmaceuticals | 3.91B |
| Sai Parenteral's | 3.81B |
| Anlon Healthcare | 1.72B |
| Gujarat Themis Biosyn | 1.66B |
IOL Chemicals and Pharmaceuticals News
- 2 months ago - IOL Chemicals and Pharmaceuticals reports promoter group acquisition of ₹40,00,210 in shares - Business Upturn
- 6 months ago - IOL Chemicals receives EDQM Certificate of Suitability for Minoxidil API - Business Upturn
- 10 months ago - IOL Chemicals shares surge nearly 3.5% after Q1 profit rises 13% YoY - Business Upturn
- 10 months ago - IOL Chemicals Q1 results: Net profit rises 13% YoY to Rs 34 crore; EBITDA margin improves to 11.4% - Business Upturn
- 1 year ago - IOL Chemicals and Pharmaceuticals shares jump nearly 5% after China approves Ibuprofen export - Business Upturn
- 1 year ago - Why are IOL Chemicals share price falling 3% today? Check here - Business Upturn
- 1 year ago - IOL Chemicals shares surge 4% after EDQM certification for Quetiapine Fumarate - Business Upturn
- 1 year ago - IOL Chemicals and Pharmaceuticals shares rise nearly 4% as board approves 1:5 stock split - Business Upturn